Application 761133

Type
BLA
Sponsor
TAKEDA PHARMS USA

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001ENTYVIOVEDOLIZUMABINJECTABLE;INTRAVENOUS300MGNoNo
002ENTYVIOVEDOLIZUMABINJECTABLE;INJECTION108MG/0.68MLNoNo

Documents

DocumentSubmission typeDate
85200SUPPL 2026-03-02
85172SUPPL 2026-02-27
79399ORIG 2024-08-15
78405SUPPL 2024-05-06
78404SUPPL 2024-05-06
78175SUPPL 2024-04-19
78174SUPPL 2024-04-19
77846SUPPL 2024-03-15
77841SUPPL 2024-03-15
77840SUPPL 2024-03-15
77628SUPPL 2024-02-26
77619SUPPL 2024-02-26
77618SUPPL 2024-02-26
75599ORIG 2023-09-28
75586ORIG 2023-09-28